Literature DB >> 15390060

Dopamine receptor gene polymorphisms in Parkinson's disease patients reporting "sleep attacks".

Ida Rissling1, Frank Geller, Oliver Bandmann, Karim Stiasny-Kolster, Yvonne Körner, Charlotte Meindorfner, Hans-Peter Krüger, Wolfgang H Oertel, J Carsten Möller.   

Abstract

Genes encoding proteins involved in dopaminergic transmission are potential candidate genes for the induction of somnolence in Parkinson's disease (PD) because dopaminergic agents have been shown to be associated with sudden onset of sleep (SOS) in PD. We conducted an association study on dopamine D2, D3, and D4 receptor gene polymorphisms comparing 137 PD patients with SOS and 137 PD patients without SOS matched according to drug therapy, disease duration, sex, and age. Our results show a significant association between the dopamine D2 receptor gene polymorphism Taq IA and SOS in PD. No significant association between two other investigated polymorphisms and the phenomenon of "sleep attacks" in PD was observed. (c) 2004 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15390060     DOI: 10.1002/mds.20245

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  13 in total

1.  Pharmacotherapy of Parkinson's disease in Germany.

Authors:  J C Möller; Y Körner; R C Dodel; C Meindorfner; K Stiasny-Kolster; A Spottke; H P Krüger; W H Oertel
Journal:  J Neurol       Date:  2005-03-16       Impact factor: 4.849

2.  Antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia: associations with dopamine and serotonin receptor and transporter polymorphisms.

Authors:  Cüneyt Güzey; Maria Gabriella Scordo; Edoardo Spina; Veslemøy Malm Landsem; Olav Spigset
Journal:  Eur J Clin Pharmacol       Date:  2007-01-17       Impact factor: 2.953

3.  Sleep disorders and daytime sleepiness in Parkinson's disease.

Authors:  Renee Monderer; Michael Thorpy
Journal:  Curr Neurol Neurosci Rep       Date:  2009-03       Impact factor: 5.081

4.  Sleep disturbances among pregnant women with history of migraines: A cross-sectional study.

Authors:  Chunfang Qiu; Ihunnaya O Frederick; Tanya Sorensen; Sheena K Aurora; Bizu Gelaye; Daniel A Enquobahrie; Michelle A Williams
Journal:  Cephalalgia       Date:  2015-01-29       Impact factor: 6.292

Review 5.  Genetics and Treatment Response in Parkinson's Disease: An Update on Pharmacogenetic Studies.

Authors:  Cristina Politi; Cinzia Ciccacci; Giuseppe Novelli; Paola Borgiani
Journal:  Neuromolecular Med       Date:  2018-01-05       Impact factor: 3.843

Review 6.  Excessive daytime sleepiness in patients with Parkinson's disease.

Authors:  Bettina Knie; M Tanya Mitra; Kartik Logishetty; K Ray Chaudhuri
Journal:  CNS Drugs       Date:  2011-03       Impact factor: 5.749

7.  Dopaminergic regulation of sleep and cataplexy in a murine model of narcolepsy.

Authors:  Christian R Burgess; Gavin Tse; Lauren Gillis; John H Peever
Journal:  Sleep       Date:  2010-10       Impact factor: 5.849

Review 8.  Sleep Attacks in Patients With Parkinson's Disease on Dopaminergic Medications: A Systematic Review.

Authors:  Eugene Y H Yeung; Andrea E Cavanna
Journal:  Mov Disord Clin Pract       Date:  2014-09-01

9.  A Systematic Review of Parkinson's Disease Pharmacogenomics: Is There Time for Translation into the Clinics?

Authors:  Vladimira Vuletić; Valentino Rački; Eliša Papić; Borut Peterlin
Journal:  Int J Mol Sci       Date:  2021-07-05       Impact factor: 5.923

Review 10.  Pharmacogenetics of Parkinson's Disease in Clinical Practice.

Authors:  Jean-Christophe Corvol; Werner Poewe
Journal:  Mov Disord Clin Pract       Date:  2016-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.